IBOV 166,934.20 ▼ 0.10% IPSA 11,042.67 ▲ 0.39% IPC MEX 64,397.45 ▼ 0.66% MERVAL 2,947,349 ▼ 1.77% COLCAP 2,452.46 ▲ 0.84% BVL PERÚ 58,104.31 ▲ 0.40% USD/BRL5.21▼ 0.19% USD/MXN17.00▼ 0.13% USD/CLP914.45▼ 0.02% USD/COP3,131▼ 0.32% USD/PEN3.36▼ 0.24% USD/ARS1,488▼ 0.02% USD/UYU40.33— 0.00% USD/PYG5,984— 0.00% USD/BOB11.54— 0.00% USD/DOP58.45— 0.00% USD/CRC446.12— 0.00% USD/GTQ7.62— 0.00% USD/HNL26.79— 0.00% USD/NIO36.62— 0.00% USD/VES770.61▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.70— 0.00% EUR/BRL6.04▲ 0.74% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 166,934.20 ▼ 0.10% IPSA 11,042.67 ▲ 0.39% IPC MEX 64,397.45 ▼ 0.66% MERVAL 2,947,349 ▼ 1.77% COLCAP 2,452.46 ▲ 0.84% BVL PERÚ 58,104.31 ▲ 0.40% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Monday, August 17, 2026

Covid-19 Brazil

Bolsonaro calls Covid vaccine being developed by São Paulo´s Butantan Institute “mandrake”

By · April 23, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Brazilian President Jair Bolsonaro attacked the São Paulo-based world-renowned Butantan Institute when inviting the Minister of Science and Technology, Marcos Pontes, to talk about a vaccine entirely produced in the country by researchers from Ribeirão Preto.

President Jair Bolsonaro called the new vaccine against Covid-19 developed by the Butantan Institute “mandrake”. The entity, which is linked to the government of São Paulo and has already developed Coronavac in partnership with the Chinese laboratory Sinovac, is now working to create a Brazilian immunizer, called Butanvac.

Mandrake. (Photo internet reproduction)
The mythical mandrake. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Bolsonaro attacked the institute when he invited the Minister of Science and Technology, Marcos Pontes, to talk about a vaccine produced entirely in the country by researchers from the State University of São Paulo in Ribeirão Preto (USP-RP). “This is 100% Brazilian, isn’t it? This is not that ‘mandrake’ vaccine from São Paulo, no? This one is 100% Brazilian. How is it? What is its name?”, provoked the president, on Thursday, 22, during a live broadcast to social networks.

The studies are being conducted at the University of São Paulo School of Medicine in Ribeirão Preto, in partnership with two private companies – Farmacore Biotechnology Ltda. in Brazil and PDS Biotechnology Corporation in the U.S. According to Marcos Pontes, the forecast is to make the new vaccine available by the end of the year.

Read: Butantan announces first home-grown Brazilian vaccine and will start testing it in humans

The announcement of the request to the National Health Regulatory Agency (Anvisa) for phase 1 and 2 tests of this immunizer was made in March. At the time, Pontes announced the initiative only hours after Butantan had announced that it is studying a totally national vaccine, the Butanvac.

Butantan is also responsible for developing the Coronavac, in partnership with the manufacturer Sinovac, from China. According to data from the government, this vaccine is the main immunization available to Brazilians today, representing more than 80% of the doses already applied.

Read: New “all Brazilian” Covid-19 vaccine is not Brazilian after all

The Butanvac technology, presented by the Butantan Institute as being 100% national, was developed last year by researchers from the Mount Sinai Institute in New York. On a later note, Butantan acknowledged that it “signed a partnership and has the license to use and explore part of the technology, which was developed by the Icahn School of Medicine of Mount Sinai Hospital in New York obtain the virus.”

President again criticizes lockdown

In Thursday’s April 22 broadcast, the president again criticized harsh social isolation measures recommended by health officials to contain the spread of the new coronavirus. “It’s been a year, and they keep doing lockdown as if it’s medicine to stop the virus. It’s actually impoverishing our population more and more,” he said.

In talking about Covid-19, the president once again defended the use of a drug with no proven efficacy against the disease. “Why can’t you talk about medicine, God in heaven? Last year I talked about medicine, and I was massacred. I took a drug last year (hydroxychloroquine). If I have a problem again, I will take it. It’s okay,” he affirmed.

Mandrake is the root of a plant, historically derived either from plants of the genus Mandragora found in the Mediterranean region or from other species, such as Bryonia alba, the English mandrake, which have similar properties.

Because mandrakes contain deliriant hallucinogenic tropane alkaloids and the shape of their roots often resembles human figures, they have been associated with a variety of superstitious practices throughout history. They have long been used in magic rituals, today also in contemporary pagan traditions such as Wicca and Odinism.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.